News

AARDEX® Group Adds etectRx to their MEMS® Adherence Hardware Ecosystem

4/29/2022

The partnership sees the integration of AARDEX’s adherence analytics software with etectRx’s ingestible adherence sensor Liege, Belgium (APRIL 28th, 2022) – Belgium-based AARDEX® Group, the...

Development of a Digital Pill and Respondent Behavioral Intervention (PrEPSteps) for HIV Pre-exposure Prophylaxis Adherence Among Stimulant Using Men Who Have Sex With Men

9/7/2021

Our ID-Cap™ System was recently utilized in a clinical study in Boston, MA resulting in a research report drafted by Principal Investigator Dr. Peter Chai...

The Case for Digital Pill Use in Clinical Trials

8/17/2021

Those who design and run clinical trials often worry about medication adherence among trial participants. Nonadherence is a significant concern in all types of clinical...

etectRx Announces Eric Buffkin as New CEO

7/30/2021

Company Founder Takes the Helm of etectRx, a Digital Health Company GAINESVILLE, Fla. (August 2, 2021) – etectRx™, Inc. (etectRx™), a privately held digital health...

WHITEPAPER: The Extraordinary Problem of Medication Nonadherence in Oncology Patients And How Digital Pills Can Make a Difference

5/4/2021

Cancer is often highly treatable due to new therapies, especially oral agents, that have improved outcomes and survival rates, and allow patients to be treated...

etectRx Announces Launch of MyTPill Study to Address Medication Adherence Among HIV+ Prescription Opioid Users

5/4/2021

GAINESVILLE, Fla. & BOSTON, Mass. (May 4, 2021) – Digital health company, etectRx, Inc., today announced the launch of a study to monitor antiretroviral therapy...

etectRx “It Already Does That”

4/30/2021

Inspiration struck the etectRx team after watching the Apple Watch Series 6 – “It Already Does That” campaign. etectRx enthusiastically created its version of “It...

A Brief Training Program to Support the Use of a Digital Pill System for Medication Adherence: Pilot Descriptive Study

4/23/2021

In partnership with our collaborators at academic medical centers in the United States, etectRx has created a simple and streamlined training program for our FDA-cleared...

The ID-Cap™ System: A Physician’s Perspective

4/14/2021

“The overall experience of our study participants so far with the ID-Cap System has been very positive. They have been able to navigate it quite...

High Patient Engagement with the ID-Cap™ System on 98.0% of Use-Days in a Clinical Study During the COVID-19 Pandemic

4/12/2021

COVID-19 caused many interruptions in clinical trials. After a brief pause in external clinical research, clinical studies involving use of the FDA-cleared ID-Cap System from...

Digital Pill Study Shows Significant Impact on Hepatitis C Treatment Adherence and Efficacy

3/5/2021

A study conducted between August 2017 and April 2019 with 288 participants for hepatitis C virus (HCV) treatment evaluated the impact of a digital medicine...

etectRx Targets Mental Health Field In Partnership With Local Health Pharmacy

2/26/2021

GAINESVILLE, Fla. (February 26, 2021) – Digital health company, etectRx, Inc., announced a signed letter of intent for a novel partnership with Local Health, Inc.,...

Sign Up for The Checkup